Tocilizumab, a novel monoclonal antibody targeting IL-6 signalling, significantly reduces disease activity in patients with rheumatoid arthritis

被引：0
|
作者：
Smolen, J. [1 ]
Beaulieu, A. [2 ]
Rubbert-Roth, A. [3 ]
Alecock, E. [4 ]
Alten, R. [5 ]
Woodworth, T. [4 ]
机构：
[1] Univ Clin Internal Med, Clin Dept Pheumatol, Vienna, Austria
[2] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada
[3] Univ Cologne, Med Clin 1, Cologne, Germany
[4] Roche Prod Ltd, Welwyn, SK, Canada
[5] Charite Univ Med Berlin, Schlosspk Clin, Dept Internal Med 2, D-13353 Berlin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [41] Exposure-Exposure Relationship of Tocilizumab, an AntiIL-6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
    Levi, Micha
    Grange, Susan
    Frey, Nicolas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (02): : 151 - 159
  • [42] IL-6 AS A MARKER OF CORONARY ARTERY DISEASE IN RHEUMATOID ARTHRITIS PATIENTS WITH CARDIOVASCULAR RISK FACTORS
    Fomicheva, O.
    Krougly, L.
    Sorokin, E.
    Tsomartova, M.
    Karpov, Y. U.
    Gerasimova, E.
    Novikova, D.
    Popkova, T.
    Nasonov, E.
    ATHEROSCLEROSIS, 2018, 275 : E249 - E250
  • [43] THE ROLE OF IL-6 IN THE ACCELERATION OF SARCOPENIA IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS
    Rapushi, E.
    Backa, T.
    Zoto, A.
    Petrela, E.
    Zicishti, E.
    Salko, V.
    Nuhaj, L.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S227 - S228
  • [44] Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition
    Fioravanti, A.
    Tenti, S.
    Bacarelli, M. R.
    Damiani, A.
    Gobbi, F. Li
    Bandinelli, F.
    Cheleschi, S.
    Galeazzi, M.
    Benucci, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 293 - 300
  • [45] EFFECTS OF IL-6 RECEPTOR INHIBITION THERAPY ON THE SERUM LEVELS OF IL-33 AND IL-6 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, I. A.
    Lee, S. J.
    Park, W.
    Park, S. H.
    Shim, S. -C.
    Baek, H. J.
    Yoo, D. -H.
    Kim, H. A.
    Lee, S. K.
    Lee, Y. J.
    Park, Y. E.
    Cha, H. -S.
    Lee, E. Y.
    Lee, E. B.
    Song, Y. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 456 - 456
  • [46] Plasma IL-6 in early rheumatoid arthritis is associated with disease activity, joint destruction, and treatment response
    Knudsen, L. S.
    Johansen, J. S.
    Ketland, M. L.
    Jacobsen, S.
    Ostergaard, M.
    Nielsen, H. J.
    Stengaard-Pedersen, K.
    Junker, P.
    Lottenburger, T.
    Ellingsen, T.
    Andersen, L. S.
    Hansen, I.
    Skjodt, H.
    Pedersen, J. K.
    Lauridsen, U. B.
    Svendsen, A.
    Tarp, U.
    Podenphant, J.
    Hansen, G.
    Lindegaard, H.
    Carvalho, A.
    Horslev-Petersen, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 151 - 151
  • [47] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis
    Miyagawa, Ippei
    Nakayamada, Shingo
    Saito, Kazuyoshi
    Hanami, Kentaro
    Nawata, Masao
    Sawamukai, Norifumi
    Nakano, Kazuhisa
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 405 - 409
  • [48] IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 288 - 300
  • [49] Vitamin D status in patients with rheumatoid arthritis: a correlation analysis with disease activity and progression, as well as serum IL-6 levels
    Polasik, Kinga
    Piotrowska, Ewa
    Lipinska, Barbara
    Witkowski, Jacek M.
    Bryl, Ewa
    Tukaj, Stefan
    ACTA BIOCHIMICA POLONICA, 2017, 64 (04) : 667 - 670
  • [50] Simvastatin reduces the disease activity in patients with rheumatoid arthritis.
    Kanda, H
    Yokota, K
    Kubo, K
    Tateishi, S
    Oshima, M
    Kohno, C
    Yamamoto, K
    Mimura, T
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S387 - S387
12345